Patent assignee · US · GOVERNMENT

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH

27Patents
27Active
27Granted
52Portfolio score

Filing activity: Mar 7, 2007 → Mar 11, 2020 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9108035B2 Methods and systems for using therapeutic, diagnostic or prophylactic magnetic agents Performing Operations; Transporting 13 Active
US9867830B2 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain Chemistry; Metallurgy 9 Active
US10912797B2 Tumor infiltrating lymphocytes and methods of therapy Chemistry; Metallurgy 9 Active
US9862679B2 Potent and selective inhibitors of monoamine transporters; method of making; and use thereof Chemistry; Metallurgy 4 Active
US9296500B2 Selective access to cryopreserved samples Emerging Cross-Sectional Technologies 4 Active
US10758614B2 Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase Chemistry; Metallurgy 3 Active
US9018371B2 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient Chemistry; Metallurgy 3 Active
US9186406B2 Compositions containing nucleosides and manganese and their uses Human Necessities 2 Active
US9084820B2 Magnetic microstructures for magnetic resonance imaging Physics 2 Active
US10017516B2 BMP inhibitors and methods of use thereof Chemistry; Metallurgy 1 Active
US9084819B2 Magnetic microstructures for magnetic resonance imaging Emerging Cross-Sectional Technologies 1 Active
US11033621B2 Combination therapies targeting tumor-associated stroma or tumor cells Human Necessities 0 Active
US10758526B2 Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways Chemistry; Metallurgy 0 Active
US12370255B2 Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response Chemistry; Metallurgy 0 Active
US10190143B2 Method for synthesizing selectively labeled RNA Chemistry; Metallurgy 0 Active
US10087148B2 Quinazolines as biogenic amine transport modulators Chemistry; Metallurgy 0 Active
US10799584B2 Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents Chemistry; Metallurgy 0 Active
US10273291B2 Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing Chemistry; Metallurgy 0 Active
US11351185B2 Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis Human Necessities 0 Active
US12064514B2 Ultrasound-sensitive peptide particles for spatially resolved molecule delivery Chemistry; Metallurgy 0 Active
US9701718B2 Adenovirus serotype 26 and serotype 35 filovirus vaccines Chemistry; Metallurgy 0 Active
US11034757B2 Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature Chemistry; Metallurgy 0 Active
US8003112B2 Meningococcal and pneumococcal conjugate vaccine and method of using same Emerging Cross-Sectional Technologies 0 Active
US10758613B2 Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells Chemistry; Metallurgy 0 Active
US11033620B2 Combination therapies targeting tumor-associated stroma or tumor cells and microtubules Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.